I. INTRODUCTION
UE to the well-defined range of protons in material, proton therapy is one of the most precise forms of cancer therapy, allowing for enhancing the sparing of surrounding healthy tissues. Nonetheless, the strong potential of this technique is D up to now not fully exploited, being based on X-ray computed tomography (CT) for the calculation of relative electron density values, a procedure resulting in uncertainties of several mm, due to the different interaction of protons and photons in matter. This problem can be overcome by means of the implementation of a proton CT technique, able to directly measuring the stopping power map using a proton beam with kinetic energy sufficient to cross the patient body [1] [2] [3] [4] [5] . This technique is based on the measurement of both the trajectory of each proton both upstream and downstream the target and the residual proton kinetic energy [3] [4] [5] [6] . The objective of the PRIMA (PRoton IMAging) project, funded by INFN CSN5, has been to prove feasibility of proton CT (pCT), by manufacturing and testing a prototype based on single-proton tracking with microstrip silicon detectors and residual energy evaluation with scintillating crystals [7] [8] [9] [10] [11] [12] [13] [14] [15] .
II. THE pCT DETECTOR SYSTEM
In view to get proton-CT images a high energy proton beam must be used, with particles exiting the patient, therefore typical energies are in the range 250-300MeV. The principle of operation of the apparatus we developed is sketched in Fig. 1. It is made by a tracker, to measure proton trajectories, and a calorimeter, to determine their residual energy [6] [7] [8] [9] .
The tracker is composed of four silicon microstrip x-y planes to measure the proton coordinates in the plane orthogonal to the beam (x-y). 
IV. FIRST TOMOGRAPHYC RECONSTRUCTIONS
To get first tomographic images, we used a PMMA phantom with a diameter of 2cm and height 4cm, equipped with two holes of 4mm and 6mm diameter respectively and length 2cm. A photograph of the phantom used on tests at 5.
Data have been acquired with 36 different projections (10 degrees steps).
In a conventional X.-ray tomographic analysis, detectors measure the radiation transmitted through the body at different incidence angles, the map of X-ray attenuation coefficient inside the body is then obtained through a tomographic reconstruction of the acquired projections using the Filtered Back Projection (FBP) algorithm, that back-projects the measured data on straight parallel lines perpendicular to the projection direction. Numerical integration was performed starting from NIST stopping power data for water. The coordinates of the porton on P3 plane, binned in a 256x256 matrix with a 200um pixel size were considered and, in case of more than one proton corresponding to the same pixel, the mean resisual energy was evaluated. Images have been reconstructed in a 256x256x256 pixel image volume using the FBP software. 
V. UP-GRADED SYSTEM
An upgrade of the prototype, using the same detector technologies but with an increased active area (5x20 cm\ higher rate capability and on-line data transfer, is now under development. The choice of the rectangular geometry was made in view of using the instrument to perform imaging of objects with a size of interest for the application (e.g. a human head) by dividing the phantom in slices. To perform a pCT measurement in a reasonable amount of time, the DAQ system should be able to readout the experimental apparatus at a rate of the order of IMHz. In fact one single projection radiography to be used to reconstruct a tomography image should be taken with a number of protons of the order of 10 6 • This number has to be multiplied by a factor of the order of 36-72 to uniformly cover the entire 3600 ending to a total acquisition time of the order of one minute. A detailed discussion about this new prototype is given in [19, 20] .
VI. CONCLUSIONS
The PRIMA (Proton IMAging) experiment is aimed at An upgraded prototype with larger active area and with improved data acquisition system is now under manufacturing in view to match requirements for pre-clinical tests.
